NAICS Demand Lane

    Biological Product (except Diagnostic) Manufacturing — Contract Opportunities

    432 total opportunities (432 active) tied to NAICS 325414 across federal, state, local, and forecast sources.
    NAICS 325414Federal + SLED432 total
    Total Opportunities
    432
    Across all indexed sources
    Active Estimate
    432
    Approximate active count
    Source Count
    3
    Federal, SLED, and forecast lanes

    Latest federal solicitations for NAICS 325414.

    AI Summary

    The NIAAA Clinical Center seeks proposals for whole exome analysis of patients to identify causes of alcohol-related disorders. This project requires consistent use of the AmpliSeq Exome enrichment system and ION sequencing platform for analytical integrity. Proposals are due by July 2, 2026.

    MD

    Posted Jun 22, 2026Due Jul 2, 2026PresolicitationNAICS 325414Sol: 75N98026Q00677
    View details

    AI Summary

    The National Institutes of Health is seeking proposals for a proteomics study using Olink Reveal kits. This research aims to explore genetic and environmental factors contributing to complex diseases, utilizing diverse -omics data collected from over 6,000 individuals. Interested bidders should prepare to engage in adv…

    MD

    Posted Jun 16, 2026Due Jun 26, 2026PresolicitationNAICS 325414Sol: 75N98026Q00642
    View details

    AI Summary

    The Department of Health and Human Services, National Institutes of Health, is presoliciting ION AmpliSeq reagents. This opportunity is categorized under NAICS code 325414, focusing on biotechnology products and laboratory reagents. Interested parties should review the attached Notice of Intent for further details.

    MD

    Posted Jun 16, 2026Due Jun 25, 2026PresolicitationNAICS 325414Sol: 75N98026Q00637
    View details

    AI Summary

    The National Institutes of Health intends to negotiate a sole source contract with Olink Proteomics Inc. for reagents compatible with the Q100 Instrument. Olink is the only vendor providing these specific reagents. Interested parties may submit capability statements by June 21, 2026, for consideration.

    MD

    Posted Jun 11, 2026Due Jun 21, 2026Special NoticeNAICS 325414Sol: NOI-CC-OLAO-26-006363
    View details

    AI Summary

    The National Institutes of Health intends to award a sole source contract for the expansion and distribution of iNDI FA13.1J cell lines to The Jackson Laboratory. This contract will support the iPSC Neurodegenerative Disease Initiative, focusing on quality control and public distribution of specific Alzheimer’s disease…

    MD

    Posted Jun 11, 2026Due Jun 23, 2026Special NoticeNAICS 325414Sol: NIH-NOI-26-PCA-NIA-01205
    View details

    AI Summary

    The National Institutes of Health is seeking proposals for rapidly autopsied postmortem human brain and blood specimens related to sporadic Alzheimer's disease, Autosomal Dominant AD, and controls. Interested parties should refer to the attached document for further details.

    MD

    Posted Jun 4, 2026Due Jun 14, 2026PresolicitationNAICS 325414Sol: PCA-NIA-05858
    View details

    AI Summary

    The National Institutes of Health is seeking quotes for a human cytokine, chemokine, and growth factor panel. This product will be used to analyze proteins in blood samples to explore biomarkers related to mood disorders and the effects of novel anti-depressants. Interested vendors should respond to this RFQ by the spe…

    MD

    Posted Jun 4, 2026Due Jun 18, 2026Combined Synopsis/SolicitationNAICS 325414Sol: 75N98026Q00516
    View details

    AI Summary

    The National Institutes of Health intends to acquire one Bio-Rad CFX Opus 96 Real-Time PCR System for the Laboratory of Receptor Biology and Gene Expression Branch. This non-competitive procurement aims to replace outdated equipment essential for gene expression analysis. Responses are due by June 15, 2026, and must in…

    MD

    Posted Jun 4, 2026Due Jun 15, 2026PresolicitationNAICS 325414Sol: 75N98026Q00517
    View details

    AI Summary

    The Department of Health and Human Services is presoliciting for Illumina Infinium Methylation Epic V2.0 Kits. This opportunity is categorized under NAICS code 325414, focusing on biotechnology products. Interested parties should review the attached Notice of Intent for further details.

    MD

    Posted May 28, 2026Due Jun 6, 2026PresolicitationNAICS 325414Sol: 75N98026Q00468
    View details

    AI Summary

    The FDA intends to award a sole source purchase order to BioIVT for metabolism-qualified cryopreserved human hepatocytes and related laboratory supplies. This acquisition follows simplified acquisition procedures and requires delivery within 7 days of award. Interested vendors may submit capability statements by May 29…

    MD

    Posted May 20, 2026Due May 29, 2026Special NoticeNAICS 325414Sol: CDER-2026-132690
    View details

    Source mix

    How this NAICS code is represented across indexed contract sources.

    federal
    355
    sled
    71
    forecast
    6

    About NAICS 325414

    This industry comprises establishments primarily engaged in manufacturing biological products, except diagnostic substances. These products include vaccines, blood components, and other biologics used in medical and pharmaceutical applications.

    Read the full NAICS definition →

    SamSearch Platform

    Stop searching. Start winning.

    AI-powered intelligence for the right opportunities, the right leads, and the right time.